Unknown

Dataset Information

0

Blocking HIV-1 Infection by Chromosomal Integrative Expression of Human CD4 on the Surface of Lactobacillus acidophilus ATCC 4356.


ABSTRACT: Lactobacillus bacteria are potential delivery vehicles for biopharmaceutical molecules because they are well-recognized as safe microorganisms that naturally inhabit the human body. The goal of this study was to employ these lactobacilli to combat human immunodeficiency virus type 1 (HIV-1) infection and transmission. By using a chromosomal integration method, we engineered Lactobacillus acidophilus ATCC 4356 to display human CD4, the HIV-1 receptor, on the cell surface. Since human CD4 can bind to any infectious HIV-1 particles, the engineered lactobacilli can potentially capture HIV-1 of different subtypes and prevent infection. Our data demonstrate that the CD4-carrying bacteria are able to adsorb HIV-1 particles and reduce infection significantly in vitro and also block intrarectal HIV-1 infection in a humanized mouse model in preliminary tests in vivo Our results support the potential of this approach to decrease the efficiency of HIV-1 sexual transmission.IMPORTANCE In the absence of an effective vaccine, alternative approaches to block HIV-1 infection and transmission with commensal bacteria expressing antiviral proteins are being considered. This report provides a proof-of-concept by using Lactobacillus bacteria stably expressing the HIV-1 receptor CD4 to capture and neutralize HIV-1 in vitro and in a humanized mouse model. The stable expression of antiviral proteins, such as CD4, following genomic integration of the corresponding genes into this Lactobacillus strain may contribute to the prevention of HIV-1 sexual transmission.

SUBMITTER: Wei W 

PROVIDER: S-EPMC6450108 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Blocking HIV-1 Infection by Chromosomal Integrative Expression of Human CD4 on the Surface of Lactobacillus acidophilus ATCC 4356.

Wei Wenzhong W   Wiggins Joshua J   Hu Duoyi D   Vrbanac Vladimir V   Bowder Dane D   Mellon Michael M   Tager Andrew A   Sodroski Joseph J   Xiang Shi-Hua SH  

Journal of virology 20190403 8


<i>Lactobacillus</i> bacteria are potential delivery vehicles for biopharmaceutical molecules because they are well-recognized as safe microorganisms that naturally inhabit the human body. The goal of this study was to employ these lactobacilli to combat human immunodeficiency virus type 1 (HIV-1) infection and transmission. By using a chromosomal integration method, we engineered <i>Lactobacillus acidophilus</i> ATCC 4356 to display human CD4, the HIV-1 receptor, on the cell surface. Since huma  ...[more]

Similar Datasets

| S-EPMC2607185 | biostudies-literature
| PRJNA1047083 | ENA
| PRJNA309675 | ENA
| PRJNA263693 | ENA
| S-EPMC206701 | biostudies-other
| S-EPMC8144323 | biostudies-literature
| S-EPMC9898752 | biostudies-literature
| S-EPMC5646407 | biostudies-literature
| PRJNA1009256 | ENA
| S-EPMC5078685 | biostudies-literature